Pfizer Chief Executive Albert Bourla told CNBC on Thursday that people may need to take Pfizer/BioNTech a third time within 12 months of being fully vaccinated. Burla said that may need to be filmed once a year.
Pfizer previously announced that its clinical trial data showed that the vaccine was very effective six months after the second dose. The data is based on more than 12,000 vaccinated participants. It will take more than six months to test the effectiveness of the vaccine, which is too early.
The Hill quoted Bourla as saying that the COVID-1
Also in the news:
►A senior official of the World Health Organization said on Thursday that the number of deaths from COVID-19 in Europe has exceeded one million, and the situation is still “serious”. Dr. Hans Kluge’s comments emphasized that Europe must remain vigilant, distance itself from society and speed up vaccination, as the virus variants have pushed new infection rates to record levels in some countries.
►This week, Sikhs across the United States held a watered down Vaisakhi celebration, and together with people of other religious beliefs, carefully observe major holidays this spring. Vaisakhi marked the day when Sikhism adopted its current form in 1699.
►The largest hospital system in Michigan is handling tents to handle emergencies because the system can handle COVID-19 patients in the suburbs of Detroit. Beaumont Health said there were more than 800 COVID patients on Thursday, compared with 500 two weeks ago and 128 at the end of February.
►Florida Commissioner of Education Richard Corcoran (Richard Corcoran) requires seniors across the state to voluntarily provide masks for students, teachers, and staff during the upcoming school year, not mandatory.
►Iran has reached a final agreement with Russia to purchase 60 million doses of Sputnik V 2 vaccine. With a population of 83 million, Iran began a 10-day lockdown on Saturday during the fourth wave of coronavirus infections.
►Connecticut will use US$10.7 million in federal funds to establish a summer study program to help students who fall behind due to long-term absenteeism and other problems related to the lack of full-time in-person study.
📈Today’s numbers: According to data from Johns Hopkins University, there are more than 31.4 million confirmed coronavirus cases in the United States and 564,000 deaths. Global total: 138 million cases and more than 2.97 million deaths. According to data from the Centers for Disease Control and Prevention, more than 250.9 million doses of vaccine have been distributed in the United States, and 194.7 million doses of vaccine have been administered.
reading What we are reading: Although still vague, pictures of the connection between the two COVID-19 vaccines and rare blood clots are beginning to surface. Read more here.
“USA Today” is tracking COVID-19 news. Keep refreshing this page to get the latest updates. Want more? Subscribe to our Coronavirus Watch newsletter to update your inbox, then join our Facebook group.
The CDC says the low number of “breakthrough cases” indicates that the vaccine is effective
The US Centers for Disease Control and Prevention has reported nearly 6,000 “breakthrough cases” of coronavirus infection despite being vaccinated-far less than 1% of the 76 million Americans who are fully vaccinated.
The Centers for Disease Control and Prevention said in an e-mail to USA Today that of the 5,800 cases, nearly 400 required hospitalization and 74 of them died. The CDC says that more than 40% of infections occur in people over the age of 60, of which 65% are women and 29% are asymptomatic.
CDC spokeswoman Kristen Nordlund (Kristen Nordlund) said: “All available vaccines have been proven effective in preventing serious illness, hospitalization and death.” “But, just like other vaccines, we It is expected that even if the vaccine works as expected, there will be thousands of breakthrough cases.”
Although the vaccine has been vaccinated, it is still expected to be infected – it has been proved that the effectiveness of the Moderna and Pfizer/BioNTech vaccines in two injections is more than 90%, and the vaccine of Johnson & Johnson’s one injection is about 70%. Experts say, but no vaccine is 100% effective.
The CDC still recommends that fully vaccinated people take preventive measures in public places, such as wearing masks, keeping at least 6 feet away from others, avoiding crowds and poorly ventilated places, and washing hands frequently.
Nordlund said: “Vaccine breakthrough infections account for a small percentage of people who are fully vaccinated.” “The CDC recommends that all qualified people as long as they have a vaccine, they should be vaccinated immediately.
Johnson & Johnson vaccine suspension creates problems for marginalized populations in Florida
The suspension of the Johnson & Johnson vaccine is an obstacle to full vaccination for health care workers, who rely on a single dose of vaccine to vaccinate more than 100,000 farm workers in Florida before they begin to move north. The healthcare network of more than 430 farm workers who are injected into Immokalee once a week will now rely on two doses of Moderna vaccine.
Network spokesperson Gabrielle O’Boyle said: “For organizations that work because of marginalization and underserved populations, inaccessible or unable to easily leave work, ensuring that patients return to the second injection is a major issue. problem.”
-Janine Zeitlin, Naples Daily News
California opens vaccinations to all adults
California and Washington opened the vaccine to all adults on Thursday. California Governor Gavin Newsom (Gavin Newsom) also urged all schools in the state to reopen, saying that there are no health barriers to bringing the state’s 6.2 million public school students back to the classroom. COVID-19 infections in California continue to decline, and more residents are vaccinated. However, the state’s decentralized education system allows 1,200 school districts to self-manage.
Newsom said Wednesday: “Money is no longer a problem.” “This is an excuse.”
The CDC says that empty middle seats can reduce contact. Will the airline make reservations?
A study released by the Centers for Disease Control and Prevention (CDC) on Wednesday showed that blocking the middle seat on an airplane can reduce the risk of COVID-19 exposure. The study, completed in collaboration with Kansas State University, found that when the middle seat is vacant, the risk of contact with “live” virus particles is reduced by 23% to 57%.
The conclusion is: “The physical alienation of aircraft passengers, including through policies such as the middle seat vacancy, can further reduce the risk of exposure to SARS-CoV-2 on the aircraft.” Airlines have abandoned the popular practice of blocking seats to maintain social status. The distance between travelers.
Delta Air Lines is the only American airline that is still blocking the middle seat in economy class, and this practice will end on May 1. Southwest Airlines stopped blocking seats on December 1. For one plane, the chief communications officer Josh Earnest said last summer that blocking seats is a public relations strategy, not a security strategy.
The committee says more data on the side effects of the rare Johnson & Johnson vaccine is needed
The Federal Advisory Committee decided on Wednesday that Johnson & Johnson will continue to suspend the use of the Johnson & Johnson COVID-19 vaccine until people understand the side effects of this rare vaccine. The committee will meet again within one week to ten days to evaluate the expected more data. According to reports, of the 7.2 million Americans who received the Johnson & Johnson vaccine, seven blood clots are extremely rare. According to reports, the last 6 cases were between 18 and 48 years old, and symptoms appeared 6 to 13 days after vaccination. One woman died and three are still hospitalized.
Some people worry that the suspension may cause harm to those who need the vaccine most, because Johnson & Johnson only needs to be injected once and it is easier to store and transport than the other two authorized vaccines. But the committee pointed out that the continued pause will not have a major impact on Americans’ ability to vaccinate.
So far, Johnson & Johnson vaccine accounts for less than 5% of the total number of vaccines injected in the United States. The other two vaccines produced by Pfizer and Modena have no such effect.
– Karen Weintraub
This article originally appeared on USA Today: COVID-19 News: California and Washington State Open Vaccine Eligibility